138 related articles for article (PubMed ID: 8786543)
1. Effect of clonidine pretreatment on naloxone-precipitated opiate withdrawal.
Rosen MI; McMahon TJ; Hameedi FA; Pearsall HR; Woods SW; Kreek MJ; Kosten TR
J Pharmacol Exp Ther; 1996 Mar; 276(3):1128-35. PubMed ID: 8786543
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics of naloxone-precipitated withdrawal in human opioid-dependent subjects.
Kanof PD; Handelsman L; Aronson MJ; Ness R; Cochrane KJ; Rubinstein KJ
J Pharmacol Exp Ther; 1992 Jan; 260(1):355-63. PubMed ID: 1731046
[TBL] [Abstract][Full Text] [Related]
3. Intrathecal clonidine: analgesia and effect on opiate withdrawal in the rat.
Milne B; Cervenko FW; Jhamandas K; Sutak M
Anesthesiology; 1985 Jan; 62(1):34-8. PubMed ID: 4038443
[TBL] [Abstract][Full Text] [Related]
4. Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal.
Caillé S; Espejo EF; Reneric JP; Cador M; Koob GF; Stinus L
J Pharmacol Exp Ther; 1999 Aug; 290(2):881-92. PubMed ID: 10411605
[TBL] [Abstract][Full Text] [Related]
5. Human pharmacology of the opioid neuropeptide dynorphin A(1-13).
Greenwald MK; Stitzer ML; Haberny KA
J Pharmacol Exp Ther; 1997 Jun; 281(3):1154-63. PubMed ID: 9190848
[TBL] [Abstract][Full Text] [Related]
6. The effect of gamma-hydroxybutyric acid on naloxone-precipitated opiate withdrawal.
Rosen MI; Pearsall HR; Woods SW; Kosten TR
Neuropsychopharmacology; 1996 Mar; 14(3):187-93. PubMed ID: 8866702
[TBL] [Abstract][Full Text] [Related]
7. Participation of different brain regions in the anti-narcotic withdrawal action of clonidine in the dependent rat.
Buccafusco JJ
Brain Res; 1990 Apr; 513(1):8-14. PubMed ID: 2350687
[TBL] [Abstract][Full Text] [Related]
8. Biochemical correlates of morphine withdrawal. 2. Effects of clonidine.
DiStefano PS; Brown OM
J Pharmacol Exp Ther; 1985 May; 233(2):339-44. PubMed ID: 4039756
[TBL] [Abstract][Full Text] [Related]
9. Clonidine suppression of noradrenergic hyperactivity during morphine withdrawal by clonidine: biochemical studies in rodents and primates.
Roth RH; Elsworth JD; Redmond DE
J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):42-6. PubMed ID: 6806253
[TBL] [Abstract][Full Text] [Related]
10. Clonidine attenuates conditioned aversion produced by naloxone-precipitated opiate withdrawal.
Kosten TA
Eur J Pharmacol; 1994 Mar; 254(1-2):59-63. PubMed ID: 8206117
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the effects of lofexidine and clonidine on naloxone-precipitated withdrawal in opioid-dependent humans.
Walsh SL; Strain EC; Bigelow GE
Addiction; 2003 Apr; 98(4):427-39. PubMed ID: 12653813
[TBL] [Abstract][Full Text] [Related]
12. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Bhateja P; Singh TG; Singh N
Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
[TBL] [Abstract][Full Text] [Related]
13. Effect of clonidine on plasma beta-endorphin, cortisol and growth hormone secretion in opiate-addicted subjects.
Gil-Ad I; Bar-Yoseph J; Smadja Y; Zohar M; Laron Z
Isr J Med Sci; 1985 Jul; 21(7):601-4. PubMed ID: 2931400
[TBL] [Abstract][Full Text] [Related]
14. Naloxone does not affect the cardiovascular, sedative or neurohormonal effects of clonidine in normal and hypertensive man.
Mathias CJ; da Costa DF; Cleary JC; Peart S
J Hypertens Suppl; 1985 Dec; 3(4):S77-9. PubMed ID: 3007707
[TBL] [Abstract][Full Text] [Related]
15. Clonidine: inpatient studies from 1978 to 1981.
Gold MS; Pottash AL; Extein I
J Clin Psychiatry; 1982 Jun; 43(6 Pt 2):35-8. PubMed ID: 7085583
[TBL] [Abstract][Full Text] [Related]
16. Reliability of sequential naloxone challenge tests.
Rosen MI; McMahon TJ; Margolin A; Gill TS; Woods SW; Pearsall HR; Kreek MJ; Kosten TR
Am J Drug Alcohol Abuse; 1995 Nov; 21(4):453-67. PubMed ID: 8561097
[TBL] [Abstract][Full Text] [Related]
17. [Naloxone doesn't determine the response of growth hormone to clonidine in obese patients].
Satta MA; Castelli A; Maussier ML; Scoppola A; Valenza V; Saletnich I; Monaco F; Roche J
C R Seances Soc Biol Fil; 1989; 183(4):337-41. PubMed ID: 2533520
[TBL] [Abstract][Full Text] [Related]
18. Effects of anaesthetic agents in interference of naloxone-induced opiate-withdrawal are dose-dependent in opiate-dependent rats.
Streel E; Dan B; Antoniali V; Clement B; Campanella S; Hanak C; Vanderlinden P; Pelc I; Verbanck P
Life Sci; 2005 Jun; 77(6):650-5. PubMed ID: 15921996
[TBL] [Abstract][Full Text] [Related]
19. Clinical utility of clonidine in opiate withdrawal.
Gold MS; Pottash AL; Extein I; Stoll A
NIDA Res Monogr; 1981 Feb; 34():95-100. PubMed ID: 6783957
[No Abstract] [Full Text] [Related]
20. The effect of clonidine on hormone release mediated through activation of opiate receptors.
Baranowska B
Cardiovasc Drugs Ther; 1990 Aug; 4(4):1113-7. PubMed ID: 1964578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
